Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Rader, Daniel J

Class:Id	Person:5244651
_displayName	Rader, Daniel J
_timestamp	2014-01-20 13:43:16
created	[InstanceEdit:5244660] Jassal, B, 2014-01-20
firstname	Daniel J
initial	DJ
surname	Rader
(author)	[LiteratureReference:5244647] Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo [LiteratureReference:5244664] The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice [LiteratureReference:6784635] Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases [LiteratureReference:6784705] Proprotein convertases [corrected] are responsible for proteolysis and inactivation of endothelial lipase [LiteratureReference:6789312] Identification of the active form of endothelial lipase, a homodimer in a head-to-tail conformation [LiteratureReference:9657868] Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport [LiteratureReference:9735920] Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease [LiteratureReference:9737763] Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia [LiteratureReference:9737765] Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia [LiteratureReference:9737776] Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study List all 13 refering instances
[Change default viewing format]

No pathways have been reviewed or authored by Rader, Daniel J (5244651)